In August, the chief executive officer of Medtronic, the world's second-largest public medtech company by revenue, sat down for a wide ranging interview with MD+DI - everything from accountable care and risk-based contracts, to globalization and various therapies that the company has developed.
This is the second video in that series where he talks about how entering into the services business is more about changing patient outcomes rather than just a play to make money. In the first video, he talked about innovation at the firm.
0 comments
Hide comments
